Fezolinetant: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Fezolinetant. Educational only — not medical advice.

Labeled uses

VEOZAH® is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.

Source: FDA labeling via NIH DailyMed (set cae9f798…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.